Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 w.r.t Incorporation of Subsidiary of the company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory Limited has incorporated a new subsidiary named Medicarenx Multispeciality Hospital Private Limited, with the Ministry of Corporate Affairs issuing the Certificate of Incorporation on December 19, 2025. The subsidiary has an authorised share capital of INR 50 Lakhs and subscribed share capital of INR 1 Lakh (10,000 equity shares of INR 10 each), with Clinitech holding 6,000 shares (60% stake), making it the subsidiary. This move follows a board meeting decision dated November 22, 2025, and is aimed at business expansion. The new subsidiary will operate in the hospital activities segment, marking Clinitech's entry into the hospital/healthcare services space beyond its existing laboratory business.
This is a modest expansion move with a small initial capital outlay of INR 1 Lakh from Clinitech. The move signals the company's intent to diversify into hospital operations, which could be a positive long-term growth signal, though the small scale limits immediate financial impact on shareholders.